GlassScriptPhysician profile
Michael Arthur Uro
NPI 1194899278
$1,365.91
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $24.32 · 2021: $80.20 · 2022: $213 · 2023: $370 · 2024: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744 · Travel and Lodging: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.94 |
| Travel and Lodging | $128.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $262.28 | 2019-2024 | Jublia |
| Cardiovascular Systems INC. | $196.32 | 2022 | |
| Abbott Laboratories | $183.27 | 2024 | Diamondback Peripheral |
| Stryker Corporation | $173.25 | 2024 | Actishield |
| Medtronic Vascular, INC. | $132.26 | 2019 | |
| Bioventus LLC | $130.95 | 2024 | Exogen Ultrasound Bone Healing System |
| Musculoskeletal Transplant Foundation INC. | $128.07 | 2023 | |
| Cook Medical LLC | $125.69 | 2023 | Zilver Ptx |
| Janssen Scientific Affairs, LLC | $18.00 | 2021 | |
| Horizon Therapeutics Plc | $15.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Uro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.